Gillis, A. et al. Critical assessment of G protein-biased agonism at the μ-opioid receptor. Trends Pharmacol. Sci. 41, 947–959 (2020). Article PubMed CAS Google Scholar Varga, B. R., Streicher, J. M. & Majumdar, S. Strategies towards safer opioid analgesics—a review of old and upcoming targets. Br. J. Pharmacol. 180, 975–993 (2023). Article PubMed CAS Google
Gillis, A. et al. Critical assessment of G protein-biased agonism at the μ-opioid receptor. Trends Pharmacol. Sci. 41, 947–959 (2020).
Google Scholar
Varga, B. R., Streicher, J. M. & Majumdar, S. Strategies towards safer opioid analgesics—a review of old and upcoming targets. Br. J. Pharmacol. 180, 975–993 (2023).
Google Scholar
Kelly, E., Conibear, A. & Henderson, G. Biased agonism: lessons from studies of opioid receptor agonists. Annu. Rev. Pharmacol. Toxicol. 63, 491–515 (2023).
Google Scholar
Volkow, N. D., Michaelides, M. & Baler, R. The neuroscience of drug reward and addiction. Physiol. Rev. 99, 2115–2140 (2019).
Google Scholar
Altier, N. & Stewart, J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 285, 208–215 (1998).
Google Scholar
Altier, N. & Stewart, J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65, 2269–2287 (1999).
Google Scholar
Wood, P. B. Role of central dopamine in pain and analgesia. Expert Rev. Neurother. 8, 781–797 (2008).
Google Scholar
Taylor, N. E. et al. The rostromedial tegmental nucleus: a key modulator of pain and opioid analgesia. Pain 160, 2524–2534 (2019).
Google Scholar
Wang, X. Q., Mokhtari, T., Zeng, Y. X., Yue, L. P. & Hu, L. The distinct functions of dopaminergic receptors on pain modulation: a narrative review. Neural Plast. 2021, 6682275 (2021).
Google Scholar
Kishikawa, Y. et al. Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity. Front. Pharmacol. 13, 988178 (2022).
Google Scholar
Noursadeghi, E., Rashvand, M. & Haghparast, A. Nucleus accumbens dopamine receptors mediate the stress-induced analgesia in an animal model of acute pain. Brain Res. 1784, 147887 (2022).
Google Scholar
Noursadeghi, E. & Haghparast, A. Modulatory role of intra-accumbal dopamine receptors in the restraint stress-induced antinociceptive responses. Brain Res. Bull. 195, 172–179 (2023).
Google Scholar
Shahani, P. et al. The interaction effects between opioidergic and D1-like dopamine receptors in the nucleus accumbens on pain-related behaviors in the animal model of acute pain. Pharmacol. Biochem. Behav. 246, 173911 (2025).
Google Scholar
Shields, B. C. et al. Deconstructing behavioral neuropharmacology with cellular specificity. Science 356, eaaj2161 (2017).
Google Scholar
Shields, B. C. et al. DART.2: bidirectional synaptic pharmacology with thousandfold cellular specificity. Nat. Methods 21, 1288–1297 (2024).
Google Scholar
Reynolds, J. N. J. et al. Coincidence of cholinergic pauses, dopaminergic activation and depolarisation of spiny projection neurons drives synaptic plasticity in the striatum. Nat. Commun. 13, 1296 (2022).
Google Scholar
Jang, H. J., McMahon Ward, R., Golden, C. E. M. & Constantinople, C. M. Acetylcholine demixes heterogeneous dopamine signals for learning and moving. Nat. Neurosci. 29, 840–850 (2026).
Google Scholar
Carroll, K. M., DeVito, E. E., Yip, S. W., Nich, C. & Sofuoglu, M. Double-blind placebo-controlled trial of galantamine for methadone-maintained individuals with cocaine use disorder: secondary analysis of effects on illicit opioid use. Am. J. Addict. 28, 238–245 (2019).
Google Scholar
Javed, T. et al. Association of status of acetylcholinesterase and ACHE gene 3’ UTR variants (rs17228602, rs17228616) with drug addiction vulnerability in pakistani population. Chem. Biol. Interact. 308, 130–136 (2019).
Google Scholar
Gawel, K., Labuz, K., Jenda, M., Silberring, J. & Kotlinska, J. H. Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression, and reinstatement of morphine-induced conditioned place preference in rats. Behav. Brain Res. 268, 169–176 (2014).
Google Scholar
Mei, D. et al. Cognitive enhancer donepezil attenuates heroin-seeking behavior induced by cues in rats. J. Integr. Neurosci. 22, 76 (2023).
Google Scholar
Buccafusco, J. J. & Bain, J. N. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: pharmacological modification by arecoline. Neuroscience 149, 487–498 (2007).
Google Scholar
Zhou, W. et al. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues. Neuroscience 144, 1209–1218 (2007).
Google Scholar
Slatkin, N. E., Rhiner, M. & Bolton, T. M. Donepezil in the treatment of opioid-induced sedation: report of six cases. J. Pain Symptom Manage. 21, 425–438 (2001).
Google Scholar
Wehrfritz, A. P. et al. Interaction of physostigmine and alfentanil in a human pain model. Br. J. Anaesth. 104, 359–368 (2010).
Google Scholar
Sun, E. C., Darnall, B. D., Baker, L. C. & Mackey, S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern. Med. 176, 1286–1293 (2016).
Google Scholar
Sutherland, T. N. et al. Preoperative vs postoperative opioid prescriptions and prolonged opioid refills among US youths. JAMA Netw. Open 7, e2420370 (2024).
Google Scholar
Lankenau, S. E. et al. Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 23, 37–44 (2012).
Google Scholar
Martinez-Rivera, A. et al. Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia. Sci. Adv. 10, eadq4779 (2024).
Google Scholar
Kumar, V. et al. Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment. J. Med. Chem. 59, 7634–7650 (2016).
Google Scholar
Zaveri, N. T., Marquez, P. V., Meyer, M. E., Hamid, A. & Lutfy, K. The nociceptin receptor (NOP) agonist AT-312 blocks acquisition of morphine- and cocaine-induced conditioned place preference in mice. Front. Psychiatry 9, 638 (2018).
Google Scholar
Coppola, J. J. & Disney, A. A. Is there a canonical cortical circuit for the cholinergic system? Anatomical differences across common model systems. Front. Neural Circuits 12, 8 (2018).
Google Scholar
Moeller, S. J. & Abi-Dargham, A. Letter to the editor: a novel therapeutic for opioid use disorder targeting the cholinergic system. Am. J. Addict. 28, 235–237 (2019).
Google Scholar
Jensen, K. P., DeVito, E. E., Yip, S., Carroll, K. M. & Sofuoglu, M. The cholinergic system as a treatment target for opioid use disorder. CNS Drugs 32, 981–996 (2018).
Google Scholar
Navratilova, E. & Porreca, F. Reward and motivation in pain and pain relief. Nat. Neurosci. 17, 1304–1312 (2014).
Google Scholar
Harris, H. N. & Peng, Y. B. Evidence and explanation for the involvement of the nucleus accumbens in pain processing. Neural Regen. Res. 15, 597–605 (2020).
Google Scholar
Beauchamp, A. et al. Whole-brain comparison of rodent and human brains using spatial transcriptomics. eLife 11, e79418 (2022).
Google Scholar
Spanagel, R., Herz, A. & Shippenberg, T. S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl Acad. Sci. USA 89, 2046–2050 (1992).
Google Scholar
Gonzales, K. K. & Smith, Y. Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions. Ann. NY Acad. Sci. 1349, 1–45 (2015).
Google Scholar
Vaccarino, F. J., Bloom, F. E. & Koob, G. F. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 86, 37–42 (1985).
Google Scholar
Corrigall, W. A. & Vaccarino, F. J. Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. Pharmacol. Biochem. Behav. 30, 443–450 (1988).
Google Scholar
Martin, T. J., Kim, S. A., Lyupina, Y. & Smith, J. E. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of β-funaltrexamine. Psychopharmacology 161, 152–159 (2002).
Google Scholar
Terashvili, M. et al. (+)-Morphine attenuates the (−)-morphine-produced conditioned place preference and the µ-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat. Eur. J. Pharmacol. 587, 147–154 (2008).
Google Scholar
Kaneko, S. et al. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 289, 633–637 (2000).
Google Scholar
Hikida, T., Kitabatake, Y., Pastan, I. & Nakanishi, S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl Acad. Sci. USA 100, 6169–6173 (2003).
Google Scholar
Witten, I. B. et al. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 330, 1677–1681 (2010).
Google Scholar
Severino, A. L. et al. µ-Opioid receptors on distinct neuronal populations mediate different aspects of opioid reward-related behaviors. eNeuro https://doi.org/10.1523/ENEURO.0146-20.2020 (2020).
Google Scholar
Sanchez, J. et al. Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonists. Cell Chem. Biol. 32, 1473–1485 (2025).
Google Scholar
Ponterio, G. et al. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum. Neuropharmacology 75, 78–85 (2013).
Google Scholar
Stoeber, M. et al. A genetically encoded biosensor reveals location bias of opioid drug action. Neuron 98, 963–976 (2018).
Google Scholar
Radoux-Mergault, A., Oberhauser, L., Aureli, S., Gervasio, F. L. & Stoeber, M. Subcellular location defines GPCR signal transduction. Sci. Adv. 9, eadf6059 (2023).
Google Scholar
Gonzales, K. K., Pare, J. F., Wichmann, T. & Smith, Y. GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J. Comp. Neurol. 521, 2502–2522 (2013).
Google Scholar
Ma, Y. Y. et al. Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons. ASN Neuro https://doi.org/10.1042/AN20110063 (2012).
Google Scholar
Banghart, M. R., Neufeld, S. Q., Wong, N. C. & Sabatini, B. L. Enkephalin disinhibits mu opioid receptor-rich striatal patches via delta opioid receptors. Neuron 88, 1227–1239 (2015).
Google Scholar
Cantor, C. R. & Schimmel, P. R. Biophysical Chemistry: Part III: The Behavior of Biological Macromolecules (Macmillan, 1980).
Bedard, M. L. et al. All hands on deck: we need multiple approaches to uncover the neuroscience behind the opioid overdose crisis. ACS Chem. Neurosci. 14, 1921–1929 (2023).
Google Scholar
Schildein, S., Huston, J. P. & Schwarting, R. K. Open field habituation learning is improved by nicotine and attenuated by mecamylamine administered posttrial into the nucleus accumbens. Neurobiol. Learn. Mem. 77, 277–290 (2002).
Google Scholar
Schildein, S., Huston, J. P. & Schwarting, R. K. Injections of tacrine and scopolamine into the nucleus accumbens: opposing effects of immediate vs delayed posttrial treatment on memory of an open field. Neurobiol. Learn. Mem. 73, 21–30 (2000).
Google Scholar
Robinson, T. E. & Berridge, K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18, 247–291 (1993).
Google Scholar
Urs, N. M., Daigle, T. L. & Caron, M. G. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. Neuropsychopharmacology 36, 551–558 (2011).
Google Scholar
Serrano, A., Aguilar, M. A., Manzanedo, C., Rodriguez-Arias, M. & Minarro, J. Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26, 1263–1271 (2002).
Google Scholar
Vezina, P., Kalivas, P. W. & Stewart, J. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 417, 51–58 (1987).
Google Scholar
Stevens, K. E., Mickley, G. A. & McDermott, L. J. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol. Biochem. Behav. 24, 1739–1747 (1986).
Google Scholar
Rada, P. V., Mark, G. P., Taylor, K. M. & Hoebel, B. G. Morphine and naloxone, IP or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol. Biochem. Behav. 53, 809–816 (1996).
Google Scholar
Fiserova, M., Consolo, S. & Krsiak, M. Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacology 142, 85–94 (1999).
Google Scholar
Mercer Lindsay, N., Chen, C., Gilam, G., Mackey, S. & Scherrer, G. Brain circuits for pain and its treatment. Sci. Transl. Med. 13, eabj7360 (2021).
Google Scholar
Millan, M. J. Descending control of pain. Prog. Neurobiol. 66, 355–474 (2002).
Google Scholar
Hnasko, T. S., Sotak, B. N. & Palmiter, R. D. Morphine reward in dopamine-deficient mice. Nature 438, 854–857 (2005).
Google Scholar
Threlfell, S. et al. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75, 58–64 (2012).
Google Scholar
Cachope, R. et al. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep. 2, 33–41 (2012).
Google Scholar
Nelson, A. B. et al. Striatal cholinergic interneurons Drive GABA release from dopamine terminals. Neuron 82, 63–70 (2014).
Google Scholar
Krok, A. C. et al. Intrinsic dopamine and acetylcholine dynamics in the striatum of mice. Nature 621, 543–549 (2023).
Google Scholar
Chantranupong, L. et al. Dopamine and glutamate regulate striatal acetylcholine in decision-making. Nature 621, 577–585 (2023).
Google Scholar
Mohebi, A., Collins, V. L. & Berke, J. D. Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation. eLife 12, e85011 (2023).
Google Scholar
Taniguchi, J. et al. Comment on ‘Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation’. eLife 13, e95694 (2024).
Google Scholar
Touponse, G. C. et al. Cholinergic modulation of dopamine release drives effortful behaviour. Nature 651, 1020–1029 (2026).
Google Scholar
Wilkinson, D. & Murray, J. Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer’s disease. Int. J. Geriatr. Psychiatry 16, 852–857 (2001).
Google Scholar
Weaver, I. A., Yousefzadeh, S. A. & Tadross, M. R. An open-source head-fixation and implant-protection system for mice. HardwareX 13, e00391 (2023).
Google Scholar
Dunn, T. W. et al. Geometric deep learning enables 3D kinematic profiling across species and environments. Nat. Methods 18, 564–573 (2021).
Google Scholar
Nath, T. et al. Using DeepLabCut for 3D markerless pose estimation across species and behaviors. Nat. Protoc. 14, 2152–2176 (2019).
Google Scholar
Check back often for more exciting news!
